Inventor · disambiguated record
Jason Tedrow
Also filed as: TEDROW JASON · TEDROW JASON S
9 granted patents·10 pending applications·37 citations·filing 2003–2023
79Inventor score
Top patents by PatentIndex Score
19 records- 0190US7491718B2Sulfonamides having antiangiogenic and anticancer activityABBOTT LAB·Filed 2003·Granted Feb 17, 2009·35 cites·3 claims
- 0270US7745448B2Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolateABBOTT LAB·Filed 2006·Granted Jun 29, 2010·2 cites·2 claims
- 0360US9296735B2Method for the preparation of thiadiazolesAMGEN INC·Filed 2013·Granted Mar 29, 2016·0 cites·5 claims
- 0456US12441741B2Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediatesAMGEN INC·Filed 2021·Granted Oct 14, 2025·0 cites·62 claims
- 0554US12351588B2Salt forms and solvates of Mcl-1 antagonistsAMGEN INC·Filed 2023·Granted Jul 8, 2025·0 cites·17 claims
- 0653US12162816B2Method of reducing aromatic nitro compoundsJOHNSON MATTHEY PLC·Filed 2019·Granted Dec 10, 2024·0 cites·14 claims
- 0753US2023136910A1Synthesis of vinylic alcohol intermediatesAMGEN INC·Filed 2021·Application pending·0 cites
- 0850US12442027B2Method of reducing aromatic nitro compoundsAMGEN INC·Filed 2019·Granted Oct 14, 2025·0 cites·15 claims
- 0948US12441681B2Synthesis of sulfonamide intermediatesAMGEN INC·Filed 2021·Granted Oct 14, 2025·0 cites·80 claims
- 1048US7745622B2Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea benzenesulfonateABBOTT LAB·Filed 2006·Granted Jun 29, 2010·0 cites·2 claims
- 1147US2016221985A1Method for the preparation of thiadiazolesBERCOT ERIC A·Filed 2016·Application pending·0 cites
- 1246US2015299182A1Crystalline forms of (1s)-1-[5-(amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diolARRAY BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 1340US2007161656A1N-(4-(4-aminothieno[2,3-d]pyrimidin-5-YL)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea crystalline form 2MELLICAN SEAN M·Filed 2006·Application pending·0 cites
- 1439US2009270424A1Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea hydrochlorideMELLICAN SEAN M·Filed 2006·Application pending·0 cites
- 1539US2007161658A1Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl) phenyl)urea camphorsulfonateMELLICAN SEAN M·Filed 2006·Application pending·0 cites
- 1639US2007161657A1Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea hydrobromideMELLICAN SEAN M·Filed 2006·Application pending·0 cites
- 1739US2007161660A1Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea maleateMELLICAN SEAN M·Filed 2006·Application pending·0 cites
- 1839US2007161661A1Crystalline N-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanesulfonateMELLICAN SEAN M·Filed 2006·Application pending·0 cites
- 1937US2004157836A1Sulfonamides having antiangiogenic and anticancer activityFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Tedrow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →